Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $45.90 USD
Change Today +0.11 / 0.24%
Volume 140.6K
NEOG On Other Exchanges
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

neogen corp (NEOG) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/17/15 - $51.98
52 Week Low
07/22/14 - $36.43
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEOGEN CORP (NEOG)

Related News

No related news articles were found.

neogen corp (NEOG) Related Businessweek News

No Related Businessweek News Found

neogen corp (NEOG) Details

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products and services for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug and pesticide residues, and general sanitation concerns; and AccuPoint rapid sanitation test for adenosine triphosphate, a chemical found in living cells. It offers its products primarily to food and feed processors, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, and dairies; laboratories; producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various regulatory agencies. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. This segment’s drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, this segment offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

926 Employees
Last Reported Date: 07/30/14
Founded in 1981

neogen corp (NEOG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $532.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $233.0K
Vice President of Animal Safety Operations
Total Annual Compensation: $213.0K
Vice President of Food Safety Operations
Total Annual Compensation: $194.0K
Compensation as of Fiscal Year 2014.

neogen corp (NEOG) Key Developments

Neogen Corporation Unveils New Disinfectants for Avian Influenza

Neogen Corporation has unveiled new agricultural biosecurity products including multiple disinfectants against avian influenza. Neogen offers the 'gold standard' of poultry facility disinfectants, DuPont's Virkon S, as well as DC&R Disinfectant, and BioSentry BioPhene and BioQuat disinfectants. The products have different applications within poultry facilities, and each product has met the US Environmental Protection Agency's (EPA) criteria for a virucidal label claim against avian influenza.

Neogen Launches Reveal® for Multi-Treenut Food Allergen Test

Neogen has developed a rapid test that can simultaneously detect the presence of six tree nuts in a single test in just 10 minutes after extraction. Neogen's new Reveal® for Multi-Treenut detects 5-10 parts per million (ppm) of almond, hazelnut, pecan, walnut, cashew and pistachio residues on environmental surfaces, as well as in rinses. The new test is simple to use and provides quick, accurate results, aiding food manufacturers in cleaning validations or verification of existing procedures to prevent cross-contamination of tree nuts within their manufacturing facilities. Reveal for Multi-Treenut is in an extremely easy lateral flow format — just dip the test's device in an extracted sample, and wait 10 minutes. If two lines develop, the test is positive for one or more of the six tree nuts. If only one line develops, the test is negative.

Neogen Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended February 28, 2015

Neogen Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended February 28, 2015. For the quarter, the company reported net income attributable to the company was $7,454,000 or $0.20 per diluted share compared to $6,575,000 or $0.18 per diluted share a year ago. Total revenue was $68,409,000 compared to $61,996,000 a year ago. This increase was aided by recent acquisitions completed by the company, and was achieved despite top line currency adjustments of approximately $1.5 million resulting from currency weakness in company's international markets. Operating income was $12,160,000 compared to $10,293,000 a year ago, primarily driven by the increased revenues. Income before tax was $11,634,000 compared to $10,253,000 a year ago. For the nine months, the company reported total revenue of $204,463,000 compared to $180,143,000 a year ago. Operating income was $38,496,000 compared to $32,400,000 a year ago. Income before tax was $37,768,000 compared to $31,878,000 a year ago. Net income attributable to the company was $24,142,000 or $0.65 per diluted share compared to $20,621,000 or $0.56 per diluted share a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEOG:US $45.90 USD +0.11

NEOG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biomerica Inc $0.92 USD +0.07
BioMerieux €103.75 EUR +4.08
OraSure Technologies Inc $6.60 USD +0.18
Roka Bioscience Inc $2.80 USD 0.00
Trinity Biotech PLC $16.15 USD -0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation NEOG Industry Range
Price/Earnings 54.1x
Price/Sales 6.2x
Price/Book 5.0x
Price/Cash Flow 53.5x
TEV/Sales 5.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGEN CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at